Nipah virus disease: epidemiological, clinical, diagnostic and legislative aspects of this unpredictable emerging zoonosis
L Bruno, MA Nappo, L Ferrari, R Di Lecce, C Guarnieri… - Animals, 2022 - mdpi.com
Simple Summary This review summarizes fundamental aspects of Nipah virus (NiV)
infection with particular emphasis on disease in swine and its zoonotic potential, focusing on …
infection with particular emphasis on disease in swine and its zoonotic potential, focusing on …
The immunobiology of Nipah virus
YJM Liew, PAS Ibrahim, HM Ong, CN Chong, CT Tan… - Microorganisms, 2022 - mdpi.com
Nipah virus (NiV) is a highly lethal zoonotic paramyxovirus that emerged in Malaysia in
1998. It is a human pathogen capable of causing severe respiratory infection and …
1998. It is a human pathogen capable of causing severe respiratory infection and …
[HTML][HTML] Learning from prepandemic data to forecast viral escape
Effective pandemic preparedness relies on anticipating viral mutations that are able to
evade host immune responses to facilitate vaccine and therapeutic design. However, current …
evade host immune responses to facilitate vaccine and therapeutic design. However, current …
Structure and design of Langya virus glycoprotein antigens
Z Wang, M McCallum, L Yan… - Proceedings of the …, 2024 - National Acad Sciences
Langya virus (LayV) is a recently discovered henipavirus (HNV), isolated from febrile
patients in China. HNV entry into host cells is mediated by the attachment (G) and fusion (F) …
patients in China. HNV entry into host cells is mediated by the attachment (G) and fusion (F) …
Subnanometer structure of an enveloped virus fusion complex on viral surface reveals new entry mechanisms
Paramyxoviruses—including important pathogens like parainfluenza, measles, and Nipah
viruses—use a receptor binding protein [hemagglutinin-neuraminidase (HN) for …
viruses—use a receptor binding protein [hemagglutinin-neuraminidase (HN) for …
Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates
No licensed vaccines or therapies exist for patients infected with Nipah virus (NiV), although
an experimental human monoclonal antibody (mAb) cross-reactive to the NiV and Hendra …
an experimental human monoclonal antibody (mAb) cross-reactive to the NiV and Hendra …
Recombinant vesicular stomatitis virus–vectored vaccine induces long-lasting immunity against Nipah virus disease
The emergence of the novel henipavirus, Langya virus, received global attention after the
virus sickened over three dozen people in China. There is heightened concern that …
virus sickened over three dozen people in China. There is heightened concern that …
Potent monoclonal antibody–mediated neutralization of a divergent Hendra virus variant
Hendra virus (HeV) and Nipah virus (NiV) are deadly zoonotic Henipaviruses (HNVs)
responsible for recurrent outbreaks in humans and domestic species of highly fatal (50 to …
responsible for recurrent outbreaks in humans and domestic species of highly fatal (50 to …
[HTML][HTML] Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase
Continuously evolving influenza viruses cause seasonal epidemics and pose global
pandemic threats. Although viral neuraminidase (NA) is an effective drug and vaccine target …
pandemic threats. Although viral neuraminidase (NA) is an effective drug and vaccine target …
Structure and supramolecular organization of the canine distemper virus attachment glycoprotein
D Kalbermatter, JM Jeckelmann… - Proceedings of the …, 2023 - National Acad Sciences
Canine distemper virus (CDV) is an enveloped RNA morbillivirus that triggers respiratory,
enteric, and high incidence of severe neurological disorders. CDV induces devastating …
enteric, and high incidence of severe neurological disorders. CDV induces devastating …